BIOADAPTIVES, INC.
BIOADAPTIVES, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets New | |||||||||||||||||
Series C Preferred Stock | - | - | - | - | - | - | 1 | - | - | - | 1 | - | |||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Marketable Securities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | |||||
Assets | |||||||||||||||||
Series D Preferred Stock | - | - | - | - | - | - | 20 | - | - | - | 20 | - | |||||
Accounts Receivable Net | - | - | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Receivables | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | - | - | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Indefinite Lived License Agreements | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Derivative Liabilities Current | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | |||||
Convertible Notes Payable | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Notes Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | 0 | - | |||||
Other Liabilities Current | - | - | - | 0 | - | - | - | - | - | - | - | - | |||||
Liabilities | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -2 | -2 | -2 | -1 | -1 | -2 | -1 | -2 | -2 | -2 | -2 | -1 | |||||
Additional Paid In Capital | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | |||||
Common Stock Share Subscribed But Unissued Subscri… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | - | - | 0 | - | |||||
Retained Earnings Accumulated Deficit | -11 | -11 | -11 | -10 | -10 | -9 | -9 | -9 | -9 | -9 | -8 | -8 | |||||
Debt Instrument Unamortized Discount | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 31 | 31 | 31 | 31 | 31 | 10 | 31 | 10 | 10 | 10 | 10 | 10 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | 1,250 | |||||
Common Stock Shares Issued | 37 | 12 | 12 | 11 | 10 | 9 | 8 | 1,232 | 1,232 | 1,155 | 6 | 776 | |||||
Shares Outstanding | 37 | 12 | 12 | 11 | 10 | 9 | 8 | 1,232 | 1,232 | 1,155 | 6 | 776 | |||||
Common Stock Capital Shares Reserved For Future Is… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -34.64% | -87.00% | -68.18% | - | - | - | - | - | - | - | - | - |
| 2025 | -1.69% | 11.85% | -14.59% | 61.02% | 18.11% | 102.17% | 10.71% | -21.43% | -42.86% | 0.00% | -34.64% | -87.00% |
| 2024 | 20.00% | -10.00% | -20.00% | 16.67% | -16.67% | -66.67% | 66.67% | 98.50% | 204.17% | -37.91% | -38.94% | -30.53% |
| 2023 | - | - | - | - | - | - | -33.33% | -55.56% | 11.11% | 10.00% | 20.00% | 10.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.04 | 0.05 | 0.09 | 0.07 | 0.18 | 0.07 | 0.15 | 0.03 | 0.00 | 0.02 | 0.05 | 0.11 | |||||
| Quick Ratio | 0.02 | 0.03 | 0.07 | 0.04 | 0.15 | 0.03 | 0.08 | 0.03 | 0.00 | 0.01 | 0.04 | 0.11 | |||||
| Working Capital | -1.78M | -2.15M | -2.14M | -1.48M | -1.15M | -1.57M | -1.46M | -1.81M | -1.92M | -1.82M | -1.66M | -1.31M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.04 | -1.06 | -1.11 | -1.08 | -1.24 | -1.07 | -1.18 | -1.03 | -1.00 | -1.03 | -1.06 | -1.29 | |||||
| Interest Coverage TTM | -4.01 | -6.65 | -14.70 | -26.22 | -25.53 | -17.05 | -6.55 | -2.69 | -2.25 | -1.56 | -1.41 | -1.33 | |||||
| Debt Ratio | 23.42 | 16.71 | 10.43 | 12.78 | 5.17 | 15.22 | 6.59 | 39.91 | 221.00 | 31.65 | 16.83 | 4.48 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.15 | 0.19 | 0.07 | 0.09 | 0.02 | 0.01 | 0.07 | 0.11 | 1.25 | 1.04 | 0.40 | 0.14 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.12 | -0.15 | -0.11 | -0.08 | -0.09 | -0.11 | -0.10 | -0.26 | -0.10 | -0.00 | - | |||||
| Free Cash Flow Per Share TTM | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.00 | -0.00 | -0.00 | -0.04 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 77.41% | 69.81% | - | - | - | - | - | - | 32.04% | 33.46% | 37.88% | 36.10% | |||||
| Operating Profit Margin TTM | -3,556.98% | -4,166.29% | -5,701.79% | -14,410.84% | -30,681.80% | -118,726.81% | -4,752.47% | -1,643.36% | -835.63% | -698.65% | -801.40% | -659.37% | |||||
| Net Profit Margin TTM | -4,553.20% | -6,186.31% | -8,523.35% | -14,091.71% | -23,749.21% | -116,976.30% | -7,097.33% | -4,004.40% | -2,170.91% | -1,968.60% | -2,494.19% | -1,863.82% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 694.07% | 3,424.74% | 44.27% | -60.49% | -90.94% | -98.18% | -55.65% | -21.61% | 172.47% | 147.57% | 66.31% | 48.73% | |||||
| Net Income Growth (1Y) | 52.24% | 86.41% | 73.26% | 39.04% | -0.86% | 7.87% | 26.20% | 68.42% | 4.81% | -10.25% | -20.45% | -56.32% | |||||
| EPS Growth (1Y) | 2.26% | 40.46% | 18.53% | 11,286.19% | 12,709.61% | 13,666.08% | -8.26% | 37.25% | -50.95% | -70.08% | 3,264.50% | -92.05% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.04 | -0.09 | -0.17 | -0.35 | -0.75 | -1.14 | -0.55 | -118.21 | -131.79 | -141.98 | -0.63 | -556.26 | |||||
| P/B TTM | -0.02 | -0.06 | -0.12 | -0.26 | -0.50 | -0.58 | -0.34 | -52.10 | -52.88 | -57.81 | -0.27 | -229.35 | |||||
| P/S TTM | 1.61 | 5.55 | 14.52 | 48.63 | 177.40 | 1,339.20 | 38.91 | 4,733.51 | 2,860.94 | 2,795.08 | 15.68 | 10,367.77 | |||||
| Market Cap | 41.16K | 132.10K | 265.39K | 381.76K | 571.05K | 903.96K | 492.93K | 94.05M | 101.62M | 103.93M | 447.88K | 262.80M | |||||
| Enterprise Value | 534.66K | 514.80K | 491.38K | 713.88K | 703.56K | 1.21M | 912.27K | 94.04M | 101.96M | 104.22M | 708.76K | 262.98M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -436.36K | -520.96K | -534.03K | -478.74K | -383.77K | -306.24K | -249.52K | -240.28K | -240.08K | -245.49K | -223.77K | -159.98K | |||||
| Net Debt | 493.50K | 382.70K | 225.98K | 332.12K | 132.51K | 303.53K | 419.35K | -11.80K | 342.86K | 294.51K | 260.88K | 173.60K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
BIOADAPTIVES, INC. (BDPT) — SEC Financial Statements & Analysis
BIOADAPTIVES, INC. (BDPT) is a pharmaceutical preparations company, incorporated in DE. BIOADAPTIVES, INC. trades on OTC as: BDPT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), BIOADAPTIVES, INC. reported a 694.07% year-over-year revenue growth, a Gross Profit Margin of 77.41% (TTM), a Debt-to-Equity ratio of -1.04x, a Price-to-Sales (P/S) ratio of 1.61x (TTM), a Price-to-Book (P/B) ratio of -0.02x (TTM), at a market cap of $41.16K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 694.07%
- Gross Profit Margin TTM
- 77.41%
- Debt To Equity
- -1.04x
- P/S TTM
- 1.61x
- P/B TTM
- -0.02x
- Market Cap
- $41.16K
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOADAPTIVES, INC. in?
BIOADAPTIVES, INC. (BDPT) operates in the Pharmaceutical Preparations industry.
What is BDPT's market cap?
BIOADAPTIVES, INC. (BDPT) has a market capitalization of $41.16K as of 2026-06-30.
What exchange does BDPT trade on?
BIOADAPTIVES, INC. (BDPT) trades on the OTC.
Where is BIOADAPTIVES, INC. incorporated?
BIOADAPTIVES, INC. is incorporated in DE.